翰思艾泰生物医药科技（武汉）股份有限公司（“翰思艾泰-B”，股票代码：03378）于2026年4月10日向香港联交所提交翌日披露报表，公告当日回购股份2万股，占公司已发行股本约0.015%。本次回购股份的每股价格区间介乎29.5港元至30.435238港元，合计耗资约60.26万港元。
回购完成后，公司已发行股本数量变更为136,112,730股，库藏股数量为106,100股。购回授权于2026年2月12日获得通过，公司可在授权范围内累计购回最多13,621,883股，且此前已根据该授权累计购回106,100股。公司确认本次交易遵守香港联合交易所有限公司证券上市规则及相关法律法规的要求。
此公告由董事长兼执行董事张发明签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.